Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world.

Crespo, Javier; Lazarus, Jeffrey V; Iruzubieta, Paula; García, Federico; García-Samaniego, Javier

Crespo, Javier; Lazarus, Jeffrey V; Iruzubieta, Paula; García, Federico; García-Samaniego, Javier.

Crespo J; Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital. Clinical and Translational Digestive Research Group, IDIVAL. Santander, Spain; School of Medicine, University of Cantabria. Santander, Spain. Electronic address: javier.crespo@scsalud.es.
Lazarus JV; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona. Barcelona, Spain.
Iruzubieta P; Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital. Clinical and Translational Digestive Research Group, IDIVAL. Santander, Spain.
García F; Microbiology Service, San Cecilio University Hospital. Instituto de Investigación Ibs. Granada, Spain.
García-Samaniego J; Liver Unit, La Paz University Hospital. CIBERehd. IdiPAZ. Madrid, Spain.

J Hepatol ; 75(1): 224-226, 2021 07.

Article in English | MEDLINE | ID: covidwho-1155526

Subject(s)

COVID-19; Hepatitis C; Europe; Hepatitis C/diagnosis; Hepatitis C/epidemiology; Hepatitis C/prevention & control; Humans; RNA, Viral; SARS-CoV-2; Spain/epidemiology; Vaccination

Keywords

COVID-19; SARS-CoV2 vaccination; Viral hepatitis elimination; hepatitis C screening

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hepatitis C / COVID-19 Type of study: Diagnostic study / Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: J Hepatol Journal subject: Gastroenterology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google